CanSino Biologics (SHSE:688185) Buildings And Improvements : ¥0.0 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is CanSino Biologics Buildings And Improvements?

CanSino Biologics's quarterly buildings and improvements increased from Sep. 2023 (¥0.0 Mil) to Dec. 2023 (¥1,274.9 Mil) but then declined from Dec. 2023 (¥1,274.9 Mil) to Mar. 2024 (¥0.0 Mil).

CanSino Biologics's annual buildings and improvements increased from Dec. 2021 (¥980.0 Mil) to Dec. 2022 (¥1,007.7 Mil) and increased from Dec. 2022 (¥1,007.7 Mil) to Dec. 2023 (¥1,274.9 Mil).

CanSino Biologics Buildings And Improvements Historical Data

The historical data trend for CanSino Biologics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Buildings And Improvements Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

84.29

84.67

980.02

1,007.69

1,274.89

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial													-	-	-	1,274.89	-

CanSino Biologics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

CanSino Biologics (SHSE:688185) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (SHSE:688185) » Definitions » Buildings And Improvements

Traded in Other Exchanges

CASBF:USA 06185:Hong Kong CJH:Germany

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (SHSE:688185) Headlines

No Headlines